Literature DB >> 26734639

MicroRNAs, signaling pathways and diseases.

Jiezhong Chen1.   

Abstract

Year:  2015        PMID: 26734639      PMCID: PMC4691010          DOI: 10.3978/j.issn.2305-5839.2015.12.16

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  21 in total

Review 1.  Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers.

Authors:  Vladimir A Krutovskikh; Zdenko Herceg
Journal:  Bioessays       Date:  2010-10       Impact factor: 4.345

2.  Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response.

Authors:  Xiaoyin Wang; Junya Takagawa; Viola C Lam; Daniel J Haddad; Diana L Tobler; Pamela Y Mok; Yan Zhang; Brian T Clifford; Kranthi Pinnamaneni; Shereen A Saini; Robert Su; Maya J Bartel; Richard E Sievers; Larry Carbone; Scott Kogan; Yerem Yeghiazarians; Michelle Hermiston; Matthew L Springer
Journal:  Sci Transl Med       Date:  2011-09-14       Impact factor: 17.956

3.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

Review 4.  The key regulatory roles of the PI3K/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration.

Authors:  Jiezhong Chen; Ross Crawford; Chen Chen; Yin Xiao
Journal:  Tissue Eng Part B Rev       Date:  2013-07-10       Impact factor: 6.389

Review 5.  Signaling pathways in HPV-associated cancers and therapeutic implications.

Authors:  Jiezhong Chen
Journal:  Rev Med Virol       Date:  2015-03       Impact factor: 6.989

Review 6.  The Akt-associated microRNAs.

Authors:  Min Xu; Yin-Yuan Mo
Journal:  Cell Mol Life Sci       Date:  2012-08-31       Impact factor: 9.261

7.  RAS signaling promotes resistance to JAK inhibitors by suppressing BAD-mediated apoptosis.

Authors:  Peter S Winter; Kristopher A Sarosiek; Kevin H Lin; Manja Meggendorfer; Susanne Schnittger; Anthony Letai; Kris C Wood
Journal:  Sci Signal       Date:  2014-12-23       Impact factor: 8.192

Review 8.  Targeting the phosphatidylinositol 3-kinase/AKT pathway for the treatment of multiple myeloma.

Authors:  J Zhu; M Wang; B Cao; T Hou; X Mao
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

Review 9.  Nanotechnology in the management of cervical cancer.

Authors:  Jiezhong Chen; Wenyi Gu; Lei Yang; Chen Chen; Renfu Shao; Kewei Xu; Zhi Ping Xu
Journal:  Rev Med Virol       Date:  2015-03       Impact factor: 6.989

Review 10.  MicroRNAs in vascular tissue engineering and post-ischemic neovascularization.

Authors:  Massimo Caputo; Jaimy Saif; Cha Rajakaruna; Marcus Brooks; Gianni D Angelini; Costanza Emanueli
Journal:  Adv Drug Deliv Rev       Date:  2015-05-14       Impact factor: 15.470

View more
  3 in total

Review 1.  Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies.

Authors:  Abdul Q Khan; Eiman I Ahmed; Noor R Elareer; Kulsoom Junejo; Martin Steinhoff; Shahab Uddin
Journal:  Cells       Date:  2019-08-05       Impact factor: 6.600

Review 2.  Label-Free MicroRNA Optical Biosensors.

Authors:  Meimei Lai; Gymama Slaughter
Journal:  Nanomaterials (Basel)       Date:  2019-11-06       Impact factor: 5.076

3.  MicroRNAs in Leukemias: A Clinically Annotated Compendium.

Authors:  Aleksander Turk; George A Calin; Tanja Kunej
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.